Task Force

Kathleen K. Harnden, MD, MBA, is a board-certified medical oncologist and internal medicine physician at Inova Schar Cancer Institute located in Fairfax, VA, specializing in the management of breast cancer with a particular focus on premenopausal women.

After completing her hematology/oncology fellowship at Duke University Medical Center, Dr. Harnden joined the Inova Schar Cancer Institute, where she applies her expertise in breast cancer care and clinical research. She is also an MBA graduate of the University of Virginia Darden School of Business, bringing a unique perspective that combines clinical excellence with strategic leadership.

Dr. Harnden's research focuses on early-phase clinical trials, breast cancer genomics, and personalized treatment approaches based on advanced diagnostic testing. She has served as a principal investigator on several Phase I clinical trials in metastatic breast cancer, working to develop novel therapies that improve patient outcomes.

A recognized leader in her field, Dr. Harnden has authored numerous publications in national journals and presented at leading oncology conferences, sharing her insights on cutting-edge advancements in breast cancer care. Through her work, she is committed to advancing the science of oncology and delivering patient-centered care to those affected by breast cancer.